Clinical trial

Acupuncture Combined With PD-1/PD-L1 Inhibitors for Advanced Lung Cancer

NCT06926140

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-06-21

PhaseNA

Study timeline

Study start (actual)2025-06-21Date precision: day

Registry last updated2025-07-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Cancersunresolved

Interventions

AcupunctureDEVICE

Sham ComparatorDEVICE

Sponsors & collaborators

Guang'anmen Hospital of China Academy of Chinese Medical Scienceslead sponsor

Mapped research locations

BeijingBeijing Municipality, China1 ChangshaHunan, China1 HefeiAnhui, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06926140 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.